Dr. John Cush RheumNow
3 years 8 months ago
Weekly (Ozempic) semaglutide SC was given for obesity, 3-6 mos to 408 pts with BMI> 27. Wt loss was 5.9% (6.7 kg) @3 mos & 10.9% (12.3 kg) @6 mos. 55%) had >10% & 8% had > 20% wt loss. NIDDM pts had less wt loss vs non-DM pts. https://t.co/LXpP5OR5GA https://t.co/ioPA9WpJu3
Dr. John Cush RheumNow
3 years 8 months ago
520 RA pts were screened with FibroScan (liver fibrosis)- F3 or F4 liver fibrosis seen 13.3% of controls vs 12.7% arthritis pts. MTX was not significantly correlated w/ higher FS scores. Liver stiffness was correlated w/ BMI, waist, male , age. https://t.co/nINWp8vbUu
The Journal of Rheumatology jrheum
3 years 8 months ago
Open Access
Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study
đź“° https://t.co/reGuRVPQSG
#dementia #rheumatoidarthritis https://t.co/0K7URVTkYO
Dr. John Cush RheumNow
3 years 8 months ago
RHEUMATOLOGISTS: have you ever ordered a Fibroscan in patients taking Methotrexate?
Dr. John Cush RheumNow
3 years 8 months ago
Dr. Kristi Kuhn & Univ of Colorado researchers have linked RA risk with the gut bacterium Subdoligranulum didolesgii. This could be pathogenically important and supports their "Mucosal origins hypothesis" to RA risk https://t.co/EMfNzWSPBK https://t.co/dp7p6vMI4W https://t.co/E1CBUPy2Wp
Dr. John Cush RheumNow
3 years 8 months ago
Hydroxychloroquine Update from ACR22
https://t.co/oqINHvpGLG https://t.co/si99jdDkSA
Dr. John Cush RheumNow
3 years 8 months ago
In GCA, Hospital Admission Is Bad News
1/3 of patients admitted w/ GCA were rehospitalized within 6 months, largely because of complications potentially related to corticosteroid therapy, researchers found in a retrospective cohort study.
https://t.co/zaWZn7F9sl https://t.co/OfuyZxNbaa
Dr. John Cush RheumNow
3 years 8 months ago
Join us for RheumNow Live this March 18-19 in Dallas, TX! We're not like other meetings--we're answering the questions you want answered.
RNL is a meeting to engage your mind and change your practice. Join us in-person or virtually!
https://t.co/bMphD12Bie https://t.co/Hx0uHAIUWd
Dr. John Cush RheumNow
3 years 8 months ago
ACP Recommends Bisphosphonates as Initial Therapy for Osteoporosis
The guideline is based on a systemic review and network meta-analysis conducted by the ACP Center for Evidence Reviews at the Portland Veteran Affairs Research Foundation.
https://t.co/Pbsjuh1Bto https://t.co/IwcH04LS4n
Sadly, too many of our rheumatology colleagues passed on in 2022. Here is an (incomplete) list of notable brethren, mentors, do-gooders and great rheumatologists:
Dr. Jack Cush reviews the best of 2022 in Rheumatology - highlights on new drug indications, breakthrough lupus therapies, new biosimilars and the multivitamin letdown.
Dr. John Cush RheumNow
3 years 8 months ago
2022 Match - Strong Appeal of Adult Rheumatology, Less So in Pediatric Rheumatology
The ACR is pleased to announce another successful recruitment season and welcomes this impressive pool of applicants to the field of rheumatology.
https://t.co/XEQCq5Pnnt https://t.co/quvxT9njI4
Dr. John Cush RheumNow
3 years 8 months ago
Extreme Global Costs of Physical Inactivity
A global, population-based study shows that physical inactivity is not only an important modifiable risk factor for NCDs and mental health conditions, it also imparts a considerable health and economic burden.
https… https://t.co/eZEW6LGpiL
Dr. John Cush RheumNow
3 years 8 months ago
Should Kids w/ MIS-C get the COVID vaccine? Yes - study of 385 pt > 5 yrs w/ Hx of multisystem inflammatory syndrome showed no serious adverse events after COVID-19 vaccination. The safety profile of COVID-19 vax is same as gen population https://t.co/dr2QBQsMhE? https://t.co/WbsUuYEsez

